Central nervous system monoamine neurotransmitter turnover in primary and obesity-related human hypertension

Clinical and Experimental Hypertension

Volumn 19, Issue 5-6, 1997, Pages 577-590

  Esler, M ^a   Lambert, G ^a   Vaz, M ^a   Thompson, J ^a   Kaye, D ^a   Kalff, V ^a   Kelly, M ^a   Turner, A ^a   Jennings, G ^a  

^a ALFRED HOSPITAL   (Australia)

Author keywords

3 methoxy 4 hydroxyphenylglycol; Brain; D ihydroxyphenylglycol; Desipramine; Dihydroxyphenylalanine; Essential hypertension; Norepinephrine; Serotonin; Trimethaphan

Indexed keywords

CONFERENCE PAPER; HUMAN; HYPERTENSION; NEUROTRANSMITTER RELEASE; NORADRENALIN BRAIN LEVEL; NORADRENALIN RELEASE; OBESITY; SEROTONIN BRAIN LEVEL; SYMPATHETIC INNERVATION;

EID: 0030761874     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641969709083171     Document Type: Conference Paper

References (24)

1. Esler, M., Lambert, G., Jennings, G. Increased regional sympathetic nervous activity in human hypertension: causes and consequences. J Hypertens. 8 (Suppl 7): S53-S57, 1990.
2. Eide, I., Kolloch, R., De Quattro, V., Miano L., Dugger, R., Van der Meulen, J. Raised cerebrospinal fluid norepinephrine in some patients with primary hypertension. Hypertension. 1: 255-260, 1979.
3. Chalmers, J., Pilowsky, P. Brainstem and bulbospinal neurotransmitter system in the control of blood pressure. J Hypertens. 9: 675-694, 1991.
4. Dahlstrom, A., Fuxe, K. Evidence for existence of monoamine-containing neurones in the central nervous system. I. Demonstration of monoamines in the cell bodies of brainstem neurones. Acta Physiol Scand. 232 (Suppl): 1-55, 1964.
5. Foote, S.L., Bloom, F.E., Aston-Jones, G. Nucleus coeruleus: New evidence of anatomical and physiological specificity. Physiol Rev. 63: 844-914, 1983.
6. Van Huysse, J.W., Bealer, S.L. Central nervous system norepinephrine release, hypotension and hyperosmolality in conscious rats. Am J Physiol. 260: R1071-1076, 1991.
7. Huangfu, D., Koshiya, N., Guyenet, P. A5 noradrenergic unit activity and sympathetic nerve discharge in rats. Am J Physiol. 261: R393-R402, 1991.
8. Huangfu, D., Hwang, L.-J., Riley, T.A., Guyenet, P. Splanchnic nerve responses to A5 area stimulation in rats. Am J Physiol. 263 (Regulatory Integrative Comp Physiol. 32): R437-R446, 1992.
9. Singewald, N., Philippu, A. Catecholamine release in the locus coeruleus is modified by experimentally induced changes in haemodynamics. Naunyn Schmiedeberg's Arch Pharmacol. 347: 21-27, 1993.
10. Strack, A.M., Sawyer, W.B., Hughes, J.H., Platt, K.B., Loewy, A.D. A general pattern of CNS innervation of the sympathetic outflow demonstrated by transneuronal pseudorabies viral infections. Brain Res. 491: 156-162, 1989.
11. Ferrier, C., Jennings, G.L., Eisenhofer, G., Lambert, G., Cox, H., Kalff, V., Kelly, M., Esler, M.D. Evidence for increased noradrenaline release from subcortical brain regions in essential hypertension. J Hypertens. 11: 1217-1227, 1993.
12. Lambert, G.W., Ferrier, C., Kaye, D., Cox, H.S., Turner, A.G., Jennings, G.L., Esler, M.D. Monoaminergic neuronal activity in subcortical brain regions in essential hypertension. Blood Pressure 3: 55-66, 1994.
13. Ross, C.A., Ruggiero, D.A., Morrison, S.F. Rostralventrolateral medulla: selective projections to the thoracic autonomie cell column from the region containing C1 adrenaline neurons. J Compar Neurol. 228: 168-185, 1984.
14. Reis, D.J. Neurons and receptors in the rostroventrolateral medulla mediating the antihypertensive actions of drugs acting on imidazoline receptors. J Cardiovasc Pharmacol. 27 (Suppl. 3): S11-S18, 1996.
15. Lambert, G.W., Ferrier, C., Kaye, D.M., Jennings, G.L., Kalff, V., Kelly, M.J., Cox, H.S., Turner, A.G., Esler, M.D. Central nervous system norepinephrine turnover in essential hypertension. In: The Imidazoline Receptor. Pharmacology, Functions, Ligands, and Relevance to Biology and Medicine, Reis, D.J., et al. eds, Annals of the New York Academy of Sciences, Vol 763: 679-694, 1995.
16. Lambert, G.W., Kaye, D.M., Lefkovits, J., Jennings, G.L., Turner, A.G., Cox, H.S., Esler, M.D., Central nervous system monoamine neurotransmitter turnover and its association with sympathetic nervous activity in treated heart failure patients. Circulation 92: 1813-1818, 1995.
17. Patel, K.P., Zhang, P.L., Krukoff, T.L. Alterations in brain hexokinase activity associated with heart failure in rats. Am J Physiol. 265: R923-R928, 1993.
18. Kaye, D.M., Lefkovits, J., Jennings, G.L., Bergin, P., Broughton, A., Esler, M.D. Adverse consequences of high sympathetic nervous activity in the failing human heart. J Am Coll Cardiology 26: 1257-1263, 1995.
19. Manolis, A.J., Olympios, C., Sifaki, M., Handanis, S., Bresnahan, M., Gavras, I, Gavras, H. Suppressing sympathetic activation in congestive heart failure: a new therapeutic strategy. Hypertension 26: 719-724, 1995.
20. 3H] epinephrine in the rat brain. J Neurochem. 12: 25-30, 1965.
21. Kaye, D.M., Lambert, G.W., Lefkovits, J,. Morris, M., Jennings, G.L., Esler, M.D. Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure. J Am Coll Cardiol. 23: 570-578, 1994.
22. Elam, M., Svensson, T.H., Thoren, P. Differentiated cardiovascular afferent regulation of the locus coeruleus and sympathetic nerves. Brain Res. 358: 77-84, 1985.
23. Lambert, G.W., Kaye, D.M., Cox, H.S., Vaz, M., Turner, A.G., Jennings, G.L., Esler, M.D. Regional 5-hydroxyindoleacetic acid production in humans. Life Sciences. 57: 255-267, 1995.
24. Rohner-Jeanrenaud, F., Jeanrenard, B. Obesity, Leptin and the brain. New Engl J Med. 334: 324-325, 1996.